Corneal Surgery
The cornea is the clear, dome-shaped surface at the front of the eye, and it does most of the work of focusing light for clear vision. Changes in prescription, distorted vision and corneal haze may occur with several corneal conditions, and examination and corneal imaging are required to determine the underlying cause. In cases where corneal damage has progressed far enough, a specialist may raise the possibility of replacing the affected tissue entirely.
These three situations are treated differently, and this page covers all three: corneal cross-linking, corneal transplantation, and laser treatment for corneal scarring. Which one applies depends entirely on the stage and cause of the corneal problem, not on personal preference between them.
Which Treatment May Be Appropriate?
Corneal Cross-Linking
Corneal cross-linking is used to reduce the likelihood of further progression in appropriately selected patients with progressive keratoconus (a progressive thinning and bulging of the cornea). It does not reverse the shape change that has already occurred.
Laser Treatment for Corneal Scarring
Laser Treatment for Corneal Scarring is used once scarring or irregular astigmatism (blurred vision caused by an uneven corneal surface) is already present, often following an injury, infection, or a previous corneal transplant, to improve clarity and reduce distortion.
Corneal Transplantation
Corneal Transplantation is considered when corneal damage, thinning or scarring has progressed beyond what cross-linking or laser treatment can address, and the affected tissue itself needs to be replaced.
A patient may need more than one treatment over time. For example, someone with progressive keratoconus may first undergo cross-linking to stabilise the cornea and later require laser treatment if significant scarring or an irregular surface develops. Keratoconus (a condition in which the cornea gradually becomes thinner and bulges outwards) can therefore require ongoing monitoring, rather than a single treatment decision.
Corneal Cross-Linking for Progressive Keratoconus
The Procedure
Riboflavin (a vitamin B2-based solution) drops are applied to the cornea until it’s fully saturated, then the eye is exposed to a controlled dose of ultraviolet-A (UV-A) light. This combination creates new molecular bonds or cross-links between the collagen fibres that make up the corneal tissue, increasing its structural rigidity.
In Plain Terms: A special vitamin solution is soaked into the cornea, then a UV light is used to strengthen the fibres holding the corneal tissue together, similar to how heat sets certain materials firm. This makes the cornea more resistant to the bulging that keratoconus causes.
Who Is an Ideal Candidate for Corneal Cross-Linking?
Candidacy is based on documented evidence that the keratoconus is actively progressing, not simply on having the diagnosis. This is generally established through:
Corneal topography or tomography (detailed imaging that maps the curvature of the cornea) repeated over 6 to 12 months, showing measurable progressive steepening
A change in glasses or contact lens prescription over that same period, beyond what would be expected from normal progression of nearsightedness or astigmatism
Reduced vision that isn't explained by any other cause
Corneal thickness, confirmed on imaging, is measured to determine whether cross-linking can be performed safely and which protocol, if any, may be appropriate
No active corneal infection, scarring or inflammation at the time of treatment
Keratoconus is most commonly diagnosed in the teenage years through the early thirties, and younger patients tend to show faster progression, which is one of the reasons earlier diagnosis and monitoring matters. This is also why an assessment does not stop at confirming the diagnosis. It has to establish whether the condition is actively getting worse right now, since that is what determines whether cross-linking is appropriate at this point in time or whether monitoring alone is still the right approach.
Recovery and Expected Results
Discomfort and light sensitivity are common for the first few days, generally managed with drops and, usually, a bandage contact lens. Vision often fluctuates for several weeks while the cornea settles. Recovery can take longer, and vision may remain unsettled for longer when the treated cornea was already more irregular or thinner at the time of treatment. Where the cornea was closer to average thickness and shape beforehand, most patients settle within the several weeks described above.
Potential Risks and Limitations
As with any corneal procedure, cross-linking carries potential risks, which may include infection, corneal haze, delayed epithelial healing, or discomfort and light sensitivity lasting longer than typically expected. For a small minority of patients, keratoconus may continue to progress despite treatment, and cross-linking does not reverse corneal shape changes that have already occurred. If progression continues or vision is meaningfully affected, further treatment may be considered. These risks and their likelihood are discussed individually during consultation and as part of the informed consent process.
Corneal Transplantation
The Procedure
Damaged corneal tissue is removed and replaced with healthy donor tissue. Depending on which layers of the cornea are affected, this may be a full-thickness transplant (penetrating keratoplasty) or a partial-thickness transplant (lamellar keratoplasty), which replaces only the specific damaged layer while preserving the patient’s own healthy corneal tissue elsewhere.
In Plain Terms: The damaged part of the cornea is removed and replaced with clear, healthy tissue from a donor. Whether the whole thickness of the cornea needs replacing, or just part of it, depends on exactly which layers have been affected.
Who Is an Ideal Candidate for Corneal Transplantation?
Corneal scarring, thinning, or disease advanced enough that vision cannot be adequately corrected with glasses, contact lenses, cross-linking, or laser treatment alone
Overall eye health that supports healing after a longer surgical recovery, since transplantation involves a more extended process than the other two treatments on this page
No active infection in the eye at the time of surgery
A realistic understanding that recovery is measured in months, not weeks, and that regular follow-up appointments continue for an extended period afterwards to monitor healing and check for tissue rejection
Because this is the most involved of the three treatments, candidacy is considered only once glasses or contact lenses, cross-linking, or laser treatment genuinely cannot achieve an adequate result, not as an earlier or default option.
Recovery and Expected Results
Vision improves gradually, typically over several months, as the transplanted tissue integrates and any sutures are adjusted or removed over time. Recovery can extend well beyond the initial months where a patient’s body responds to the donor tissue more slowly, or if any signs of tissue rejection require additional treatment; this is part of why follow-up continues for an extended period after surgery. Where healing progresses without complication, most patients see steady improvement across that same multi-month timeframe.
Potential Risks and Limitations
Because transplantation is a more involved procedure than cross-linking or laser treatment, its risk profile is broader. Potential risks may include infection, graft rejection, graft failure, elevated eye pressure, astigmatism or other refractive changes, and wound-related complications. Graft rejection, if it occurs, can happen at any stage after surgery and is generally treatable when identified early through regular follow-up or patients reporting symptoms. In a small number of cases, a repeat transplant may be needed. Recovery takes place over several months, with monitoring continuing for the life of the graft. These risks and their likelihood are discussed individually during consultation and as part of the informed consent process.
Laser Treatment for Corneal Scarring and Post-Transplant Astigmatism
The Procedure
A therapeutic excimer laser (a laser that removes microscopic amounts of tissue with precision) is used to treat select corneal conditions. Phototherapeutic keratectomy (PTK) may be used for selected superficial corneal scars or irregularities, improving corneal clarity. Separately, customised excimer laser techniques (such as PRK) may be considered for selected cases of refractive error or astigmatism following corneal transplantation.
In Plain Terms: A precise laser gently vaporises scar tissue and smooths out the irregular or scarred surface of the cornea, similar in concept to how PRK reshapes a cornea for vision correction, but aimed specifically at improving an already-damaged surface rather than correcting a standard glasses prescription.
Who Is an Ideal Candidate for Laser Treatment?
- Existing corneal scarring shallow enough to be treated with surface smoothing, rather than requiring a transplant
- Astigmatism remaining after a previous corneal transplant that hasn’t settled through other means
- A cornea with adequate remaining thickness to safely undergo laser treatment, confirmed through imaging beforehand
- No active infection or inflammation at the time of treatment
Recovery and Expected Results
Recovery generally ranges from two days to a few weeks, depending on how much of the corneal surface requires treatment. Where a larger area was treated, or where the patient’s cornea heals more slowly, recovery extends towards the longer end of that range. Where a smaller, more limited area was treated, most patients settle within the shorter end.
Potential Risks and Limitations
Potential risks of laser treatment may include infection, corneal haze, delayed surface healing, or undercorrection and overcorrection of the treated area. Improvement can be partial in some cases, and some patients continue to need glasses, contact lenses or further treatment afterwards. For patients treated after a corneal transplant, laser treatment may carry an additional risk of graft rejection, which is assessed individually beforehand. These risks and their likelihood are discussed during consultation and as part of the informed consent process.
Why an Accurate Assessment Matters
Corneal conditions can look similar to a patient from the inside, blurred or changing vision, without revealing which corneal condition is present and which treatment options may be appropriate. Treating early, progressive keratoconus as though it were stable scarring means the condition continues to worsen untreated. Conversely, considering a transplant before confirming that cross-linking or laser treatment could achieve an adequate result on their own means accepting a longer, more involved recovery that may not have been necessary. Getting the stage right, through corneal imaging and a documented history of change over time rather than a single visual impression, is what determines whether a patient receives the least invasive treatment capable of addressing their specific condition.
Dr David Robinson trained specifically in corneal disease through fellowships in Melbourne and Jerusalem and has performed corneal transplant and cross linking and corneal laser procedures across more than 28 years of practice. During your assessment, he will examine the structure and health of your cornea, review how your condition has changed over time, and explain which treatment options are appropriate for your eyes.
Common Questions Patients Ask
Can keratoconus be cured?
Cross-linking does not cure keratoconus or restore the cornea to its original shape. It aims to halt further progression, although progression can still occur in some patients. Glasses, contact lenses or additional treatment may still be required.
How long does a corneal transplant last?
Many transplants remain healthy for decades, though this varies between patients and depends on ongoing eye health and adherence to follow-up care. Long-term monitoring remains important for the life of the transplant.
Is corneal cross-linking painful?
It isn’t painful during the treatment itself, since the eye is numbed with anaesthetic eyedrops beforehand. Discomfort and light sensitivity in the days afterwards are common and are generally manageable with a bandage contact lens and prescribed drops.
Will a patient still need glasses after any of these treatments?
Often yes. These treatments aim to stabilise or restore the cornea’s structure rather than eliminate a glasses prescription entirely, which is a different goal from procedures like LASIK or PRK.
How is it decided which of these three treatments applies?
This depends on whether the keratoconus is actively progressing, whether scarring is already present, and how much corneal tissue remains healthy, all of which are established through corneal imaging and examination rather than symptoms alone.